Concepedia

Author

Karen Sliwa

University of Cape TownORCID

Also Known As

A. M. Dirir, Antonio L. Dans, B Alamro, Candice K Silversides, Catherine Otto, F Ruschitzka, G. Minana, J P Gnanaraj, Jose Pomar, K SLIWA

655

Publications

38.5K

Citations

92

H-Index

173

Concepts

All Affiliations

University of Cape TownUniversity of the WitwatersrandGroote Schuur HospitalChris Hani Baragwanath HospitalEduardo Mondlane University
KS

About

Karen Sliwa is an author at University of Cape Town specializing in medicine, cardiovascular disease, and public health.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

38

64

7.2K

2

Health Sciences

2

2

281

3

Business

1

1

99

4

Engineering

1

1

482

5

Natural Sciences

1

1

881

Karen Sliwa

×

211

Publications

22.4K

Citations

69

H-Index

YearCitations

Association of psychosocial risk factors with risk of acute myocardial infarction in 11 119 cases and 13 648 controls from 52 countries (the INTERHEART study): case-control study

Annika Rosengren, Steven Hawken, Stephanie Ôunpuu,

The Lancet

2004

2.4K

Safety, tolerability and efficacy of up-titration of guideline-directed medical therapies for acute heart failure (STRONG-HF): a multinational, open-label, randomised, trial

Alexandre Mebazaa, Beth A. Davison, Ovidiu Chioncel,

The Lancet

2022

882

A Cathepsin D-Cleaved 16 kDa Form of Prolactin Mediates Postpartum Cardiomyopathy

Denise Hilfiker‐Kleiner, Karol Kamiński, Edith Podewski,

Cell

2007

881

Cholesterol Lowering in Intermediate-Risk Persons without Cardiovascular Disease

Salim Yusuf, Jackie Bosch, Gilles R. Dagenais,

New England Journal of Medicine

2016

827

Cardiac Myosin Activation with Omecamtiv Mecarbil in Systolic Heart Failure

John R. Teerlink, Rafael Díaz, G. Michael Felker,

New England Journal of Medicine

2020

625

Blood-Pressure Lowering in Intermediate-Risk Persons without Cardiovascular Disease

Eva Lonn, Jackie Bosch, Patricio López‐Jaramillo,

New England Journal of Medicine

2016

610

The Causes, Treatment, and Outcome of Acute Heart Failure in 1006 Africans From 9 Countries

Albertino Damasceno, Bongani M. Mayosi, Mahmoud U. Sani,

Archives of Internal Medicine

2012

511

Evaluation of Bromocriptine in the Treatment of Acute Severe Peripartum Cardiomyopathy

Karen Sliwa, Lori A. Blauwet, Kemi Tibazarwa,

Circulation

2010

485

MicroRNA-146a is a therapeutic target and biomarker for peripartum cardiomyopathy

Julie Halkein, Sébastien P. Tabruyn, Melanie Ricke‐Hoch,

Journal of Clinical Investigation

2013

482

Pathophysiology, Diagnosis and Management of Peripartum Cardiomyopathy: A Position Statement from the Heart Failure Association of the European Society of Cardiology Study Group on Peripartum Cardiomyopathy

Johann Bauersachs, Tobias König, Peter van der Meer,

European Journal of Heart Failure

2019

409

Page 1